These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9619164)

  • 1. Worsening of obsessive-compulsive symptoms following treatment with olanzapine.
    Morrison D; Clark D; Goldfarb E; McCoy L
    Am J Psychiatry; 1998 Jun; 155(6):855. PubMed ID: 9619164
    [No Abstract]   [Full Text] [Related]  

  • 2. Olanzapine-induced obsessive-compulsive disorder.
    Mottard JP; de la Sablonnière JF
    Am J Psychiatry; 1999 May; 156(5):799-800. PubMed ID: 10327925
    [No Abstract]   [Full Text] [Related]  

  • 3. Emergence of compulsive symptoms with olanzapine treatment.
    Mahendran R
    Aust N Z J Psychiatry; 2002 Aug; 36(4):565. PubMed ID: 12169167
    [No Abstract]   [Full Text] [Related]  

  • 4. Obsessive-compulsive symptoms during treatment with olanzapine and risperidone: a prospective study of 113 patients with recent-onset schizophrenia or related disorders.
    de Haan L; Beuk N; Hoogenboom B; Dingemans P; Linszen D
    J Clin Psychiatry; 2002 Feb; 63(2):104-7. PubMed ID: 11874209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olanzapine and obsessive-compulsive symptoms.
    Lykouras L; Zervas IM; Gournellis R; Malliori M; Rabavilas A
    Eur Neuropsychopharmacol; 2000 Sep; 10(5):385-7. PubMed ID: 10974610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obsessive-compulsive symptoms in schizophrenia: a comparison of olanzapine and placebo.
    Baker RW; Ames D; Umbricht DS; Chengappa KN; Schooler NR
    Psychopharmacol Bull; 1996; 32(1):89-93. PubMed ID: 8927681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olanzapine-sertraline combination in schizophrenia with obsessive-compulsive disorder.
    Poyurovsky M; Kurs R; Weizman A
    J Clin Psychiatry; 2003 May; 64(5):611. PubMed ID: 12755669
    [No Abstract]   [Full Text] [Related]  

  • 8. Provocation of obsessive-compulsive behaviour and tremor by olanzapine.
    al-Mulhim A; Atwal S; Coupland NJ
    Can J Psychiatry; 1998 Aug; 43(6):645. PubMed ID: 9729696
    [No Abstract]   [Full Text] [Related]  

  • 9. Priapism associated with polypharmacy.
    Seger A; Lamberti JS
    J Clin Psychiatry; 2001 Feb; 62(2):128. PubMed ID: 11247100
    [No Abstract]   [Full Text] [Related]  

  • 10. Reply to Dr Mahendran. We have not found reported cases of [obsessive-compulsive] OC arising from de novo with olanzapine treatment.
    Safranko I
    Aust N Z J Psychiatry; 2003 Feb; 37(1):112. PubMed ID: 12534671
    [No Abstract]   [Full Text] [Related]  

  • 11. Olanzapine treatment of obsessive-compulsive disorder.
    Degner D; Bleich S; Kornhuber J; Rüther E
    Can J Psychiatry; 2000 May; 45(4):393. PubMed ID: 10813075
    [No Abstract]   [Full Text] [Related]  

  • 12. Antidepressant augmentation with low-dose olanzapine in obsessive-compulsive disorder.
    Marusic A; Farmer A
    Br J Psychiatry; 2000 Dec; 177():567. PubMed ID: 11270368
    [No Abstract]   [Full Text] [Related]  

  • 13. Olanzapine-induced obsessive-compulsive symptoms in a patient with bipolar II disorder.
    Jonkers F; De Haan L
    Psychopharmacology (Berl); 2002 Jun; 162(1):87-8. PubMed ID: 12107623
    [No Abstract]   [Full Text] [Related]  

  • 14. Beneficial effect of olanzapine in schizophrenic patients with obsessive-compulsive symptoms.
    Poyurovsky M; Dorfman-Etrog P; Hermesh H; Munitz H; Tollefson GD; Weizman A
    Int Clin Psychopharmacol; 2000 May; 15(3):169-73. PubMed ID: 10870875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Open-label olanzapine in obsessive-compulsive disorder refractory to antidepressant treatment.
    Crocq MA; Leclercq P; Guillon MS; Bailey PE
    Eur Psychiatry; 2002 Sep; 17(5):296-7. PubMed ID: 12381502
    [No Abstract]   [Full Text] [Related]  

  • 16. Effectiveness of olanzapine treatment for severe obsessive-compulsive disorder.
    Marazziti D; Pallanti S
    Am J Psychiatry; 1999 Nov; 156(11):1834-5. PubMed ID: 10553756
    [No Abstract]   [Full Text] [Related]  

  • 17. Olanzapine-induced agranulocytosis.
    Naumann R; Felber W; Heilemann H; Reuster T
    Lancet; 1999 Aug; 354(9178):566-7. PubMed ID: 10470705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The paradox of quetiapine in obsessive-compulsive disorder.
    Tranulis C; Potvin S; Gourgue M; Leblanc G; Mancini-Marie A; Stip E
    CNS Spectr; 2005 May; 10(5):356-61. PubMed ID: 15858452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Obsessive-compulsive disorders in adolescents with diagnosed schizophrenia].
    Rabe-Jabłońska J
    Psychiatr Pol; 2001; 35(1):47-57. PubMed ID: 11324381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypersalivation coincident with olanzapine treatment.
    Perkins DO; McClure RK
    Am J Psychiatry; 1998 Jul; 155(7):993-4. PubMed ID: 9659875
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.